Tesamorelin adds visceral fat reduction (directly addressing the obesity component), improved body composition (supporting metabolic rate), and potential cardiovascular benefits through reduction of the inflammatory visceral fat depot
The more you resist experiencing those things, the more likely those manifestations will be stronger and more intense the next time the same situation occurs, she says
A small study also found that those taking a GLP-1 drug were more sensitive to taste than those taking a placebo
You can read the abstract of this article at In this study, the researchers compared the effects of tirzepatide, a novel treatment for type 2 diabetes, with insulin degludec using continuous glucose monitoring (CGM)
Trial SOUL (McGuire et al., NEJM 2025) Design Phase 3 / event-driven Population Adults with T2D + ASCVD or CKD Key result Oral semaglutide significantly reduced MACE vs placebo in high-CV-risk T2D